Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
McKinsey
Moodys
Boehringer Ingelheim
Express Scripts

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CORTISONE ACETATE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Cortisone Acetate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00489840 Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate Completed Alcon Research Phase 1/Phase 2 2007-05-01 Investigation to evaluate Anecortave Acetate in the treatment of chronic central serous chorioretinopathy
NCT00489840 Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate Completed LuEsther T. Mertz Retinal Research Center Phase 1/Phase 2 2007-05-01 Investigation to evaluate Anecortave Acetate in the treatment of chronic central serous chorioretinopathy
NCT00489840 Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate Completed Manhattan Eye, Ear & Throat Hospital Phase 1/Phase 2 2007-05-01 Investigation to evaluate Anecortave Acetate in the treatment of chronic central serous chorioretinopathy
NCT00915343 Once-daily Oral Modified Release Hydrocortisone in Patients With Adrenal Insufficiency Completed Shire Phase 2/Phase 3 2007-08-01 This is a randomised, controlled, open, two-armed, two-period cross-over, multi-centre phase II/III study to assess the safety, tolerability and pharmacokinetics of once-daily oral modified-release hydrocortisone in comparison to conventional thrice-daily oral hydrocortisone tablets in patients with adrenal insufficiency
NCT01771328 Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia Recruiting Haukeland University Hospital Phase 2 2013-02-01 The conventional glucocorticoid replacement therapy in congenital adrenal hyperplasia (CAH) renders the cortisol levels unphysiological, which may cause symptoms and long-term complications. Glucocorticoid replacement is technically feasible by continuous subcutaneous hydrocortisone infusion (CSHI), and can mimic the normal diurnal cortisol rhythm. This method was recently applied to treat a patient through a critical phase of puberty. This is a clinical trial aiming to evaluate CSHI treatment in patients with CAH. The main objective is to determine the effects of CSHI on metabolic parameters (androstenedione and 17-hydroxyprogesterone profiles, and testosterone,adrenocorticotropic hormone(ACTH), cortisol, and bone markers), and to determine the required glucocorticoid doses. Secondary objectives are to determine effects on clinical status, body weight, blood pressure and other metabolic parameters, as well as on subjective health status (AddiQoL, SF36).
NCT01847690 Effect of Cortisol on Physical Exertion in Patients With Primary Adrenal Failure Unknown status Haukeland University Hospital Phase 2 2013-06-01 The conventional glucocorticoid replacement therapy in primary adrenal insufficiency- Addison's disease,renders the cortisol levels unphysiological, which may cause symptoms and long-term complications. Many patients take stress-doses that are extra doses of hydrocortisone or cortisone acetate before or during stressful physical or psychological events. However, the effect of such dosing has not been tested in scientific studies. In this double blind cross-over designed pilot trial we aim to test the effect of an extra dose of cortisol on physical activity and hormone levels.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Cortisone Acetate

Condition Name

Condition Name for Cortisone Acetate
Intervention Trials
Addison Disease 1
Flail Chest 1
Degeneration of Lumbar or Lumbosacral Intervertebral Disc 1
Chronic Central Serous Chorioretinopathy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Cortisone Acetate
Intervention Trials
Hyperplasia 1
Flail Chest 1
Adrenogenital Syndrome 1
Atrial Fibrillation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Cortisone Acetate

Trials by Country

Trials by Country for Cortisone Acetate
Location Trials
Norway 2
Israel 1
United States 1
Brazil 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Cortisone Acetate
Location Trials
New York 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Cortisone Acetate

Clinical Trial Phase

Clinical Trial Phase for Cortisone Acetate
Clinical Trial Phase Trials
Phase 4 1
Phase 2/Phase 3 2
Phase 2 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Cortisone Acetate
Clinical Trial Phase Trials
Completed 3
Recruiting 2
Not yet recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Cortisone Acetate

Sponsor Name

Sponsor Name for Cortisone Acetate
Sponsor Trials
Haukeland University Hospital 2
Hadassah Medical Organization 1
Shire 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Cortisone Acetate
Sponsor Trials
Other 8
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
McKinsey
Johnson and Johnson
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.